New partnerships with national Complex Rehab Technology (CRT) and prosthetics/orthotics providers are expected to grow Ekso Bionics’ Personal Health Products segment for 2025, the company announced during its May 5 earnings call. Ekso Bionics (Nasdaq: EKSO) reported earnings results for the three months ending on March 31, 2025, while also commenting on what the company…
Ekso Bionics Q1 Earnings: Partnerships with NSM, Bionic P&O Expected to Grow Personal Health Products Segment This Year
NSM Earns Accreditation Gold Seal of Approval from The Joint Commission
The reaccreditation process included unannounced onsite reviews at locations nationwide.
National Seating & Mobility (NSM) has again earned The Joint Commission’s Gold Seal of Approval for home care accreditation, the Complex Rehab Technology (CRT) and accessibility provider announced. “NSM is honored to receive the home care reaccreditation from The Joint Commission,” said Crispin Teufel, NSM CEO, in an April 7 press release. “This recognition reaffirms…
Ekso Bionics to Focus on Indego Personal Exoskeleton Expansion Through CRT, DME Channels
The company shared its plans during a March 3 earnings call.
In an earnings call covering its 2024 full-year results, executives from Ekso Bionics (Nasdaq: EKSO) described the company’s plans to get its Ekso Indego Personal exoskeleton into the hands of more patients. “Revenue of $17.9 million was down from $18.3 million for the same period in 2023,” Ekso Bionics CFO Jerome Wong said, in describing…
Report: National Seating & Mobility Seeks $1.5 Billion Valuation
A private-equity publication said Cinven could be looking to sell the Complex Rehab Technology provider.
National Seating & Mobility (NSM), a Nashville, Tennessee-based provider of Complex Rehab Technology (CRT) and home accessibility equipment in the United States and Canada, is being shopped for acquisition, according to reporting in PE Hub. Global private equity firm Cinven acquired NSM in 2019 for $850 million. PE Hub reported that the firm is now…